Aclarion Announces Reverse Stock Split
BROOMFIELD, CO, Jan. 02, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq:ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced that effective before market open on Thursday January 4, 2024, it will complete a 1-for-16 reverse stock split of its common stock.
Related news for (ACON)
- Spider Silk, Spines, and Satoshi — Innovation Headlines Today’s Movers
- Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
- 24/7 Market News Snapshot 13 October, 2025 – Aclarion, Inc. Common Stock (NASDAQ:ACON)
- Today’s Top Performers: MoBot’s Market Review 10/13/25 04:00 AM
- MoBot’s Stock Market Highlights – 10/10/25 04:00 PM
